Qubit Pharmaceuticals nominated for “Best start-up 2024” award by Prix Galien USA

Qubit Pharmaceuticals has been nominated for the 2024 edition of the prestigious Prix Galien USA, in the “Best Startup” category, out of a field of 41 companies, including 15 French contenders.